TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: graft dysfunction progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rehabilitation of postpartum low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fatal major bleeds
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD34+ cell yield of the first apheresis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Platelet recovery at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of respiratory triggers (RT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of breath stacking
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: drinks per day reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield of histological specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in hypomania
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intima-media thickness (IMT) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiorespiratory fitness (V˙o2peak)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in IC/BPS symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: enjoyment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proliferative diabetic retinopathy (PDR) conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Eye outcomes
Primary endpoint: Cataract surgery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Visual acuity gain (≥10 letters)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of NAFLD development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of significant liver fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good to excellent outcome based on Thoresen criteria
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: lifestyle change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: metformin use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CoVar of respiratory cycle total time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: CoVar of tidal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of participants who stepped down or off PPI
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reported breakthrough symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum lipid-lowering capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total per patient treatment costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ISI reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1 AUC0‐4h improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: sensitivity of brush cytology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D-5L index value
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: intra-operative remifentanil requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BAL fluid recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QALY reduction
Endpoint domain: Mortality/survival
Primary endpoint: health-care savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: medical insurance payment increase
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient effort during pediatric ventilation liberation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Core outcome set for treatment of uncomplicated acute appendicitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Healthcare resource consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Assessment of whole body fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CMV‐DNAemia of > 50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV‐1 vertical transmission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antenatal plasma HIV‐1‐RNA load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean final transfer test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rScO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: LUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Intraoperative pain scores
Endpoint domain: Adverse events/effects
Primary endpoint: Weight monitoring frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Documentation of HF-related signs/symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of eating disorders onset
Endpoint domain: Mortality/survival
Primary endpoint: Pain domain of the EuraHS QoL questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: recurrence after NA withdrawals
Endpoint domain: Mortality/survival
Primary endpoint: Intensity of early onset swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Aesthetic improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: DASS-21 posttest scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: BLS assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neuromuscular activation of trunk muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Risk of developing a second PGTCS
Endpoint domain: Mortality/survival
Primary endpoint: Freedom from PGTCS at end of the 24-week treatment period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction from baseline in PGTCS frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ninety-day post-treatment mortality
Endpoint domain: Mortality/survival
Primary endpoint: Median postoperative survival time
Endpoint domain: Mortality/survival
Primary endpoint: 1- and 5-year overall survivals
Endpoint domain: Mortality/survival
Primary endpoint: facial contour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: biophysical parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in the largest dimension of the lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in pathogen count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Recovery from reported pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Ability to walk 15m with assistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: additional seizures
Endpoint domain: Adverse events/effects
Primary endpoint: CCI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of proper handwashing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of risks of open defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of safe toilet types
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in serum and red cell α‐TOH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attenuation of postrun CK increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in wrinkle score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: improvement in cheek skin elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: mean postoperative tramadol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients requiring additional analgesia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Limb activity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dose of oral analgesic within 72 h
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of NEC (Bell stage 2 or 3)
Endpoint domain: Adverse events/effects
Primary endpoint: Time to achieve full enteral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visuospatial working memory impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: semantic memory impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: oral language impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: word writing impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence and duration of mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intensity of pain due to mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: liquid within the graft
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tunnel size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: signal noise quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived Need
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: unplanned hospital readmissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: cardiac rehabilitation completion
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: UILR (Unilateral Limb Revascularization)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Successful implantation at first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Visual analog scale of muscle soreness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour milk production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean milk transfer volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of ACR in patients with microalbuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction of HOMA-IR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dose Length Product (DLP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 18-month Pap rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Survival (OS) at 3 and 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Plasma levels of CXCL10, CXCL8, CXCL9, CXCL11, and CXCL13 after 24 weeks of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KSS pain and function scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stone-free rate at 3 months after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean number of needle punctures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: median duration of needle puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean plasma concentrations of carnitines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean plasma levels of FAAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time for finishing the treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children with treatment interruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean errors in SI and LR directions after radiotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TBLH BMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: A-type JCMA index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: somatic symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total SPADI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of asthenopia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensorineural functions of the visual analyzer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accommodative and oculomotor functions of the visual analyzer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline diabetes prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Baseline hyperlipidemia prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incident diabetes prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Absolute Refractive Error (MARE) of the second eyes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diurnal sleepiness
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: pulmonary function (FEF 25%-75%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: time to first HF event or CV death
Endpoint domain: Mortality/survival
Primary endpoint: correct diagnosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SBSES scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MSS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total wound-closure cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: recording quality of home sleep apnea test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MEV90 of 0.2% ropivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MEC90 of 1.5 ml ropivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant diarrhea (grade ≥2)
Endpoint domain: Adverse events/effects
Primary endpoint: Neutropenia (grade ≥3)
Endpoint domain: Adverse events/effects
Primary endpoint: Carriage of CTX resistance genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: posttreatment anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Understanding of antibiotic effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Belief about reducing antibiotic dose
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: working memory performance post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-frequency component of heart rate variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: adequate tissue samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cellularity quantitative scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diameter of the histological sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the number of bacteria on the tongue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Increase in physical activity (PA) hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Growth of patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of spinal cord injury (SCI)
Endpoint domain: Mortality/survival
Primary endpoint: Discrimination ability of the Rad-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrimination ability of the clinical-radiomics nomogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for Arclight ophthalmoscope
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Histologic diagnosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frailty improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in urinary frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: decrease in urgency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: decrease in dysuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: NIF-BUT score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Schirmer I test score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival edema
Endpoint domain: Adverse events/effects
Primary endpoint: Gingival overgrowth
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of loosening in the postoperative period
Endpoint domain: Adverse events/effects
Primary endpoint: Catastrophic health expenditure (CHE)
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Out-of-pocket payments (OOPs)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Poverty caused by OOPs
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: first-pass success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in anhedonia severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone loss at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final implant quotient stability (ISQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean dose reduction from OBTCM in nDbreast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crohn's Disease Activity Index reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAMD-17 score improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal Plaque Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: submaximal exercise systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SSD of ATT at foot strike
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death or disability at 24 months of corrected age
Endpoint domain: Mortality/survival
Primary endpoint: In-breast tumor recurrence (IBTR) rates
Endpoint domain: Mortality/survival
Primary endpoint: positive parenting skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of CT-QFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: rise from the floor velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in CA 15-3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients alive and without respiratory failure through day 28
Endpoint domain: Mortality/survival
Primary endpoint: End-Diastolic Velocity (EDV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: VGS gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-Physician Communication (PPC)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brachial artery diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: child social performance in school
Endpoint domain: Life impact
Endpoint subdomain: Social functioning